279 related articles for article (PubMed ID: 30476975)
1. Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European Patients.
Tichelli A; Beohou E; Labopin M; Socié G; Rovó A; Badoglio M; van Biezen A; Bader P; Duarte RF; Basak G; Salooja N;
JAMA Oncol; 2019 Feb; 5(2):229-235. PubMed ID: 30476975
[TBL] [Abstract][Full Text] [Related]
2. Second cancers and late mortality in Australian children treated by allogeneic HSCT for haematological malignancy.
Nelson AS; Ashton LJ; Vajdic CM; Le Marsney RE; Daniels B; Nivison-Smith I; Wilcox L; Dodds AJ; O'Brien TA;
Leukemia; 2015 Feb; 29(2):441-7. PubMed ID: 24962016
[TBL] [Abstract][Full Text] [Related]
3. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
[TBL] [Abstract][Full Text] [Related]
4. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
5. Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease.
Atsuta Y; Suzuki R; Yamashita T; Fukuda T; Miyamura K; Taniguchi S; Iida H; Uchida T; Ikegame K; Takahashi S; Kato K; Kawa K; Nagamura-Inoue T; Morishima Y; Sakamaki H; Kodera Y;
Ann Oncol; 2014 Feb; 25(2):435-41. PubMed ID: 24399081
[TBL] [Abstract][Full Text] [Related]
6. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of patients who developed subsequent solid cancer after hematopoietic cell transplantation.
Inamoto Y; Matsuda T; Tabuchi K; Kurosawa S; Nakasone H; Nishimori H; Yamasaki S; Doki N; Iwato K; Mori T; Takahashi S; Yabe H; Kohno A; Nakamae H; Sakura T; Hashimoto H; Sugita J; Ago H; Fukuda T; Ichinohe T; Atsuta Y; Yamashita T;
Blood Adv; 2018 Aug; 2(15):1901-1913. PubMed ID: 30087108
[TBL] [Abstract][Full Text] [Related]
8. Second solid cancers after allogeneic hematopoietic stem cell transplantation.
Gallagher G; Forrest DL
Cancer; 2007 Jan; 109(1):84-92. PubMed ID: 17131350
[TBL] [Abstract][Full Text] [Related]
9. Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant.
Dandoy CE; Kim S; Chen M; Ahn KW; Ardura MI; Brown V; Chhabra S; Diaz MA; Dvorak C; Farhadfar N; Flagg A; Ganguly S; Hale GA; Hashmi SK; Hematti P; Martino R; Nishihori T; Nusrat R; Olsson RF; Rotz SJ; Sung AD; Perales MA; Lindemans CA; Komanduri KV; Riches ML
JAMA Netw Open; 2020 Jan; 3(1):e1918668. PubMed ID: 31913492
[TBL] [Abstract][Full Text] [Related]
10. Increase of suicide and accidental death after hematopoietic stem cell transplantation: a cohort study on behalf of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Tichelli A; Labopin M; Rovó A; Badoglio M; Arat M; van Lint MT; Lawitschka A; Schwarze CP; Passweg J; Socié G
Cancer; 2013 Jun; 119(11):2012-21. PubMed ID: 23512286
[TBL] [Abstract][Full Text] [Related]
11. Epileptic seizures in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors, and survival rates.
Zhang XH; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Liu KY; Huang XJ
Clin Transplant; 2013; 27(1):80-9. PubMed ID: 22938074
[TBL] [Abstract][Full Text] [Related]
12. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease.
Binks M; Passweg JR; Furst D; McSweeney P; Sullivan K; Besenthal C; Finke J; Peter HH; van Laar J; Breedveld FC; Fibbe WE; Farge D; Gluckman E; Locatelli F; Martini A; van den Hoogen F; van de Putte L; Schattenberg AV; Arnold R; Bacon PA; Emery P; Espigado I; Hertenstein B; Hiepe F; Kashyap A; Kötter I; Marmont A; Martinez A; Pascual MJ; Gratwohl A; Prentice HG; Black C; Tyndall A
Ann Rheum Dis; 2001 Jun; 60(6):577-84. PubMed ID: 11350846
[TBL] [Abstract][Full Text] [Related]
13. Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study.
Cohen A; Rovelli A; Merlo DF; van Lint MT; Lanino E; Bresters D; Ceppi M; Bocchini V; Tichelli A; Socié G
J Clin Oncol; 2007 Jun; 25(17):2449-54. PubMed ID: 17557958
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic inflammatory demyelinating diseases of the central nervous system in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors and survival.
Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Wang M
Chin Med J (Engl); 2013 Mar; 126(6):1096-102. PubMed ID: 23506585
[TBL] [Abstract][Full Text] [Related]
15. Survival of patients who develop solid tumors following hematopoietic stem cell transplantation.
Ehrhardt MJ; Brazauskas R; He W; Rizzo JD; Shaw BE
Bone Marrow Transplant; 2016 Jan; 51(1):83-8. PubMed ID: 26367222
[TBL] [Abstract][Full Text] [Related]
16. Potential Risks to Stable Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Children With Cerebral X-linked Adrenoleukodystrophy.
Kühl JS; Kupper J; Baqué H; Ebell W; Gärtner J; Korenke C; Spors B; Steffen IG; Strauss G; Voigt S; Weschke B; Weddige A; Köhler W; Steinfeld R
JAMA Netw Open; 2018 Jul; 1(3):e180769. PubMed ID: 30646031
[TBL] [Abstract][Full Text] [Related]
17. Role of Allogeneic Hematopoietic Stem Cell Transplant for Chronic Granulomatous Disease (CGD): a Report of the United States Immunodeficiency Network.
Yonkof JR; Gupta A; Fu P; Garabedian E; Dalal J;
J Clin Immunol; 2019 May; 39(4):448-458. PubMed ID: 31111420
[TBL] [Abstract][Full Text] [Related]
18. [Clinical analysis of acute renal failure after allogeneic hematopoietic stem cell transplantation].
Zhou T; Cen XN; Qiu ZX; Ou JP; Wang WS; Xu WL; Li Y; Wang MJ; Wang LH; Tong YJ; Ren HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):723-8. PubMed ID: 19549395
[TBL] [Abstract][Full Text] [Related]
19. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J
Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
[TBL] [Abstract][Full Text] [Related]
20. Neurological Complications Involving the Central Nervous System After Allogeneic Hematopoietic Stem Cell Transplantation During a Period of Evolution in Transplant Modalities: A Cohort Analysis.
Colombo AA; Marchioni E; Diamanti L; Di Matteo AM; Baldanti F; Furione M; Cazzola M; Ferretti VV; Pascutto C; Alessandrino EP
Transplantation; 2017 Mar; 101(3):616-623. PubMed ID: 27222935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
